Publications in collaboration with researchers from University of Liverpool (37)

2025

  1. Analysis of key proinflammatory mechanisms in cardiovascular pathology through stimulation with lipopolysaccharide and urban particulate matter in mouse atrial cardiomyocytes

    Environmental Toxicology and Pharmacology, Vol. 114

  2. Atrial fibrillation versus atrial myopathy in thrombogenesis: Two sides of the same coin?

    Trends in Cardiovascular Medicine

  3. Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures

    Nature Reviews Cardiology, Vol. 22, Núm. 4, pp. 273-303

  4. Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation

    Journal of Nutrition, Health and Aging, Vol. 29, Núm. 1

  5. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study

    Clinical cardiology, Vol. 48, Núm. 2, pp. e70102

  6. The use of oral anticoagulation at the time of acute COVID-19 infection and subsequent development of long-COVID/post-acute sequelae of SARS-CoV-2 infection

    Journal of Thrombosis and Thrombolysis

2024

  1. Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis

    European Journal of Clinical Investigation, Vol. 54, Núm. 12

  2. Navigating the bleeding risk dilemma in patients with atrial fibrillation on therapy with direct-acting oral anticoagulants: Comparing the HAS-BLED vs. DOAC Score

    European Journal of Internal Medicine

  3. Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study

    Internal and Emergency Medicine, Vol. 19, Núm. 7, pp. 1941-1948

2023

  1. Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  2. Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis

    Clinical Cardiology, Vol. 46, Núm. 6, pp. 656-662

  3. Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy

    Current Problems in Cardiology, Vol. 48, Núm. 10

  4. Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis

    European Journal of Internal Medicine

  5. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making

    American Heart Journal, Vol. 258, pp. 1-16

  6. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review

    Science of the Total Environment, Vol. 880

  7. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

    Biomedicine and Pharmacotherapy, Vol. 158

  8. Response to letter from Du et al. regarding article ‘Sodium-glucose cotransporter-2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?’

    Diabetes, Obesity and Metabolism

  9. Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia

    Heart and Lung, Vol. 59, pp. 61-66

  10. Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis

    Internal and Emergency Medicine, Vol. 18, Núm. 2, pp. 423-428

2022

  1. Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients

    Thrombosis and Haemostasis, Vol. 122, Núm. 3, pp. 406-414